{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:46:16Z","timestamp":1794008776600,"version":"4.8.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010413","name":"Rene Baron Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2019-02987"],"award-info":[{"award-number":["PICT 2019-02987"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2020-01552"],"award-info":[{"award-number":["PICT 2020-01552"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Argentina Ministry of Science Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"National Agency for the Promotion of Research Technological Development and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008777","name":"Bunge y Born Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008777","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"National Scientific and Technical Research Council","doi-asserted-by":"publisher","award":["PIP 938"],"award-info":[{"award-number":["PIP 938"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cytogfr.2024.10.002","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T22:11:19Z","timestamp":1729375879000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation"],"prefix":"10.1016","volume":"80","author":[{"given":"Ignacio M.","family":"Seropian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"El-Diasty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham H.","family":"El-Sherbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n E.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel A.","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2024.10.002_bib1","doi-asserted-by":"crossref","first-page":"1304735","DOI":"10.3389\/fphys.2023.1304735","article-title":"Unraveling the role of Galectin-3 in cardiac pathology and physiology","volume":"14","author":"Seropian","year":"2023","journal-title":"Front Physiol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib2","first-page":"8696543","article-title":"Galectin-1 as an emerging mediator of cardiovascular inflammation: mechanisms and therapeutic opportunities","author":"Seropian","year":"2018","journal-title":"Mediat. Inflamm. 2018"},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molmed.2023.11.013","article-title":"Glycosylation of blood cells during the onset and progression of atherosclerosis and myocardial infarction","volume":"30","author":"Ferro","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"12","key":"10.1016\/j.cytogfr.2024.10.002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105400","article-title":"The universe of galectin-binding partners and their functions in health and disease","volume":"299","author":"Troncoso","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.002_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","article-title":"Targeting galectin-driven regulatory circuits in cancer and fibrosis","volume":"22","author":"Marino","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-021-00713-x","article-title":"Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses","volume":"28","author":"Hong","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41590-020-00844-7","article-title":"Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarmin","volume":"22","author":"Russo","year":"2021","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib8","first-page":"247","article-title":"Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues","volume":"26","author":"Sundblad","year":"2011","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131386","article-title":"Galectin-3 contributes to acute cardiac dysfunction and toxicity by increasing oxidative stress and fibrosis in doxorubicin-treated mice","author":"Seropian","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.002_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. J. Heart Fail"},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.002_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101215","article-title":"Heart failure after ST-elevation myocardial infarction: beyond left ventricular adverse remodeling","volume":"48","author":"Del Buono","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ajpath.2015.12.017","article-title":"Myocardial galectin-3 expression is associated with remodeling of the pressure-overloaded heart and may delay the hypertrophic response without affecting survival, dysfunction, and cardiac fibrosis","volume":"186","author":"Frunza","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.002_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cellbi.2006.11.036","article-title":"Expression and immunohistochemical localization of galectin-3 in various mouse tissues","volume":"31","author":"Kim","year":"2007","journal-title":"Cell Biol. Int."},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.002_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273542","article-title":"Knockdown of CD146 promotes endothelial-to-mesenchymal transition via Wnt\/beta-catenin pathway","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ. Heart Fail"},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.002_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107300","article-title":"Defining the mechanism of galectin-3-mediated TGF-beta1 activation and its role in lung fibrosis","volume":"300","author":"Calver","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"5693","key":"10.1016\/j.cytogfr.2024.10.002_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1102109","article-title":"Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis","volume":"306","author":"Partridge","year":"2004","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.002_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming growth factor-beta in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib19","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin","volume":"296","author":"Liu","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.002_bib20","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1084\/jem.20090121","article-title":"Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response","volume":"207","author":"Markowska","year":"2010","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.cytogfr.2024.10.002_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12872-016-0298-z","article-title":"Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation","volume":"16","author":"Coromilas","year":"2016","journal-title":"BMC Cardiovasc Disord."},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.002_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jchf.2016.06.010","article-title":"Circulating Galectin-3 levels are persistently elevated after heart transplantation and are associated with renal dysfunction","volume":"4","author":"Grupper","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11897-010-0004-x","article-title":"Galectin-3 in cardiac remodeling and heart failure","volume":"7","author":"de Boer","year":"2010","journal-title":"Curr. Heart Fail Rep."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.14813","article-title":"Galectin-3 levels and long-term all-cause mortality and hospitalization in heart failure patients: a meta-analysis","author":"Cheng","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14592","article-title":"Galectin-3 as an independent prognostic factor after heart transplantation","volume":"36","author":"Franekova","year":"2022","journal-title":"Clin. Transpl."},{"issue":"19","key":"10.1016\/j.cytogfr.2024.10.002_bib26","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.HYP.0000215579.81408.8e","article-title":"Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction","volume":"47","author":"Klotz","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.002_bib28","first-page":"4106","article-title":"Therapeutic inhibition of galectin\u20113 improves cardiomyocyte apoptosis and survival during heart failure","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.002_bib29","doi-asserted-by":"crossref","first-page":"H2372","DOI":"10.1152\/ajpheart.00283.2011","article-title":"A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone","volume":"301","author":"Lopez-Andres","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.002_bib30","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Martinez-Martinez","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","article-title":"The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries","volume":"3","author":"Calvier","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib32","doi-asserted-by":"crossref","first-page":"H1287","DOI":"10.1152\/ajpheart.00096.2016","article-title":"Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension","volume":"311","author":"Gonzalez","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/HJH.0000000000001545","article-title":"Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats","volume":"36","author":"Martinez-Martinez","year":"2018","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00018-022-04623-5","article-title":"YAP-galectin-3 signaling mediates endothelial dysfunction in angiotensin II-induced hypertension in mice","volume":"80","author":"Pang","year":"2023","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.002_bib35","doi-asserted-by":"crossref","first-page":"H1226","DOI":"10.1152\/ajpheart.00305.2007","article-title":"Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage","volume":"294","author":"Sharma","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"25","key":"10.1016\/j.cytogfr.2024.10.002_bib36","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1074\/jbc.M116.721464","article-title":"Low or no inhibitory potency of the canonical galectin carbohydrate-binding site by pectins and galactomannans","volume":"291","author":"Stegmayr","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib37","first-page":"1199","article-title":"Galectin-3 expression in human atherosclerotic lesions","volume":"152","author":"Nachtigal","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib38","doi-asserted-by":"crossref","first-page":"5284728","DOI":"10.1155\/2020\/5284728","article-title":"Galectin-3 Is a potential mediator for atherosclerosis","author":"Gao","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/oxfordjournals.jbchem.a021762","article-title":"Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a beta-galactoside-binding lectin","volume":"122","author":"Rabinovich","year":"1997","journal-title":"J. Biochem."},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.002_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm7322","article-title":"Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm","volume":"8","author":"Roldan-Montero","year":"2022","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.002_bib41","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib42","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.ijcard.2013.12.129","article-title":"Galectin-3 expression in cardiac remodeling after myocardial infarction","volume":"172","author":"Sanchez-Mas","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.002_bib43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.hlc.2016.11.007","article-title":"Myocardial and serum Galectin-3 expression dynamics marks post-myocardial infarction cardiac remodelling","volume":"26","author":"Sharma","year":"2017","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/1177271918771969","article-title":"The therapeutic potential of blocking Galectin-3 expression in acute myocardial infarction and mitigating inflammation of infarct region: a clinical outcome-based translational study","volume":"13","author":"Mosleh","year":"2018","journal-title":"Biomark. Insights"},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.002_bib45","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.celrep.2015.02.012","article-title":"Microglia-secreted Galectin-3 Acts as a toll-like receptor 4 ligand and contributes to microglial activation","volume":"10","author":"Burguillos","year":"2015","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00395-019-0746-x","article-title":"Neutrophil proteome shifts over the myocardial infarction time continuum","volume":"114","author":"Daseke","year":"2019","journal-title":"Basic Res. Cardiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib47","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1189\/jlb.1204702","article-title":"Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses","volume":"78","author":"Nieminen","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109816","article-title":"Neutrophil signaling during myocardial infarction wound repair","volume":"77","author":"Daseke","year":"2021","journal-title":"Cell Signal"},{"key":"10.1016\/j.cytogfr.2024.10.002_bib49","first-page":"9247574","article-title":"The many roles of Galectin-3, a multifaceted molecule, in innate immune responses against pathogens","author":"Diaz-Alvarez","year":"2017","journal-title":"Mediat. Inflamm. 2017"},{"key":"10.1016\/j.cytogfr.2024.10.002_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvad116","article-title":"Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades","author":"Wang","year":"2023","journal-title":"Cardiovasc Res."},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.002_bib51","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.ajpath.2020.05.010","article-title":"Genetic Deletion of Galectin-3 alters the temporal evolution of macrophage infiltration and healing affecting the cardiac remodeling and function after myocardial infarction in mice","volume":"190","author":"Cassaglia","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.002_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030729","article-title":"Ultrasonic microbubble cavitation deliver Gal-3 shRNA to inhibit myocardial fibrosis after myocardial infarction","volume":"15","author":"Li","year":"2023","journal-title":"Pharmaceutics"},{"issue":"14","key":"10.1016\/j.cytogfr.2024.10.002_bib53","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400747R","article-title":"The detrimental role of galectin-3 and endoplasmic reticulum stress in the cardiac consequences of myocardial ischemia in the context of obesity","volume":"38","author":"Jimenez-Gonzalez","year":"2024","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.cytogfr.2024.10.002_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008510","article-title":"Small endogeneous peptide mitigates myocardial remodeling in a mouse model of cardioselective Galectin-3 overexpression","volume":"14","author":"Sonkawade","year":"2021","journal-title":"Circ. Heart Fail"},{"issue":"Pt A","key":"10.1016\/j.cytogfr.2024.10.002_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2015.06.025","article-title":"Galectin-3 and post-myocardial infarction cardiac remodeling","volume":"763","author":"Meijers","year":"2015","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajpath.2012.09.022","article-title":"Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction","volume":"182","author":"Seropian","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.002_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1039\/D1MO00519G","article-title":"Macrophages secrete murinoglobulin-1 and galectin-3 to regulate neutrophil degranulation after myocardial infarction","volume":"18","author":"Chalise","year":"2022","journal-title":"Mol. Omics"},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.002_bib58","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","article-title":"Regulation of alternative macrophage activation by galectin-3","volume":"180","author":"MacKinnon","year":"2008","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cytogfr.2024.10.002_bib59","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.4049\/jimmunol.1201851","article-title":"Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication","volume":"189","author":"Dragomir","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"M.L. Entman, The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis","year":"2002","journal-title":"Cardiovasc Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.002_bib61","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1159\/000494539","article-title":"Myocardial ischemia reperfusion injury: apoptotic, inflammatory and oxidative stress role of Galectin-3","volume":"50","author":"Al-Salam","year":"2018","journal-title":"Cell Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib62","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1038\/s41598-019-46119-6","article-title":"Myocardial injury after ischemia\/reperfusion is attenuated by pharmacological Galectin-3 inhibition","volume":"9","author":"Ibarrola","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172701","article-title":"Cardioprotective effects of galectin-3 inhibition against ischemia\/reperfusion injury","volume":"863","author":"Mo","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108602","article-title":"Galectin-3 knock down inhibits cardiac ischemia-reperfusion injury through interacting with bcl-2 and modulating cell apoptosis","volume":"694","author":"Zhang","year":"2020","journal-title":"Arch. Biochem Biophys."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carpath.2005.10.006","article-title":"Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction","volume":"15","author":"Vandervelde","year":"2006","journal-title":"Cardiovasc Pathol."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.002_bib66","doi-asserted-by":"crossref","first-page":"H1056","DOI":"10.1152\/ajpheart.00459.2021","article-title":"Guidelines for in vivo mouse models of myocardial infarction","volume":"321","author":"Lindsey","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.cytogfr.2024.10.002_bib67","doi-asserted-by":"crossref","first-page":"H1553","DOI":"10.1152\/ajpheart.00158.2018","article-title":"Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury","volume":"315","author":"Toldo","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.cytogfr.2024.10.002_bib68","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/cvr\/cvz050","article-title":"Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities","volume":"115","author":"Andreadou","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib69","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1160\/TH07-01-0022","article-title":"Chemokines in ischemia and reperfusion","volume":"97","author":"Frangogiannis","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.cytogfr.2024.10.002_bib70","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1073\/pnas.92.4.1213","article-title":"Identification of galectin-3 as a factor in pre-mRNA splicing","volume":"92","author":"Dagher","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2007.01.003","article-title":"Rodent models of heart failure","volume":"56","author":"Balakumar","year":"2007","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib72","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s11427-022-2189-x","article-title":"Galectin-3-centered paracrine network mediates cardiac inflammation and fibrosis upon beta-adrenergic insult","volume":"66","author":"Hu","year":"2023","journal-title":"Sci. China Life Sci."},{"issue":"3","key":"10.1016\/j.cytogfr.2024.10.002_bib73","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HYPERTENSIONAHA.115.06161","article-title":"Inhibition of Galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice","volume":"67","author":"Vergaro","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib74","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1038\/s41598-018-26115-y","article-title":"Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure","volume":"8","author":"Nguyen","year":"2018","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.cytogfr.2024.10.002_bib75","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/bph.14674","article-title":"Stimulation of beta-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway","volume":"176","author":"Zhao","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112178","article-title":"Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4\/JAK\/STAT3 pathway","volume":"143","author":"Li","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib77","first-page":"1","article-title":"Protective effect of Galectin-3 inhibitor against cardiac remodelling in an isoprenaline-induced myocardial infarction in type 2 diabetes","author":"Mahmoud","year":"2024","journal-title":"Arch. Physiol. Biochem"},{"issue":"1","key":"10.1016\/j.cytogfr.2024.10.002_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clim.2008.08.024","article-title":"Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice","volume":"130","author":"Mensah-Brown","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.714683","article-title":"Transgenic overexpression of Galectin-3 in pancreatic beta cells attenuates hyperglycemia in mice: synergistic antidiabetic effect with exogenous IL-33","volume":"12","author":"Jovicic","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.868372","article-title":"Galectin-3 inhibition ameliorates streptozotocin-induced diabetic cardiomyopathy in mice","volume":"9","author":"Zhu","year":"2022","journal-title":"Front. Cardiovasc Med."},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.002_bib81","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1139\/cjpp-2019-0708","article-title":"Galectin-3 mediates high-glucose-induced cardiomyocyte injury by the NADPH oxidase\/reactive oxygen species pathway","volume":"98","author":"Sun","year":"2020","journal-title":"Can. J. Physiol. Pharm."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib82","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ajpath.2017.01.016","article-title":"Association of cardiac Galectin-3 expression, myocarditis, and fibrosis in chronic chagas disease cardiomyopathy","volume":"187","author":"Souza","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib83","article-title":"Galectins in chagas disease: a missing link between trypanosoma cruzi infection, inflammation, and tissue damage","volume":"12","author":"Poncini","year":"2021","journal-title":"Front. Microbiol."},{"issue":"19","key":"10.1016\/j.cytogfr.2024.10.002_bib84","first-page":"1882","article-title":"Chagas' disease","volume":"373","author":"Bern","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib85","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2249.2001.01512.x","article-title":"Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease","volume":"124","author":"Giordanengo","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2020.107932","article-title":"Galectin-3 mediates survival and apoptosis pathways during Trypanosoma cruzi-host cell interplay","volume":"216","author":"Chain","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib87","first-page":"3282656","article-title":"Galectin-3 knockdown impairs survival, migration, and immunomodulatory actions of mesenchymal stromal cells in a mouse model of chagas disease cardiomyopathy","author":"Souza","year":"2017","journal-title":"Stem Cells Int 2017"},{"issue":"10","key":"10.1016\/j.cytogfr.2024.10.002_bib88","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1139\/cjpp-2019-0700","article-title":"Galectin-3 inhibition attenuates doxorubicin-induced cardiac dysfunction by upregulating the expression of peroxiredoxin-4","volume":"98","author":"Tian","year":"2020","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153786","article-title":"Effect of modified citrus pectin on galectin-3 inhibition in cisplatin-induced cardiac and renal toxicity","volume":"504","author":"Santos","year":"2024","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.002_bib90","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004867","article-title":"A small peptide Ac-SDKP inhibits radiation-induced cardiomyopathy","volume":"11","author":"Sharma","year":"2018","journal-title":"Circ. Heart Fail"},{"issue":"2","key":"10.1016\/j.cytogfr.2024.10.002_bib91","first-page":"214","article-title":"Sirtuin 2 exerts regulatory functions on radiation-induced myocardial fibrosis in mice by mediating H3K27 acetylation of Galectin-3 promoter","volume":"40","author":"Chen","year":"2024","journal-title":"Acta Cardiol. Sin."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib92","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad126","article-title":"Sudden cardiac death after heart transplantation: a population-based study","volume":"25","author":"Bonnet","year":"2023","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.cytogfr.2024.10.002_bib93","first-page":"899","article-title":"Circulating Galectin-3 following heart transplant: long-term dynamics and prognostic value","volume":"72","author":"Suarez-Fuentetaja","year":"2019","journal-title":"Rev. Esp. Cardiol."},{"issue":"5","key":"10.1016\/j.cytogfr.2024.10.002_bib94","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/glycob\/cwi026","article-title":"Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways","volume":"15","author":"Fernandez","year":"2005","journal-title":"Glycobiology"},{"issue":"8","key":"10.1016\/j.cytogfr.2024.10.002_bib95","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/1354750X.2012.719037","article-title":"Galectin 3 complements BNP in risk stratification in acute heart failure","volume":"17","author":"Fermann","year":"2012","journal-title":"Biomarkers"},{"key":"10.1016\/j.cytogfr.2024.10.002_bib96","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/j.jmb.2016.03.021","article-title":"Shaping the immune landscape in cancer by galectin-driven regulatory pathways","volume":"428","author":"Rabinovich","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib97","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.febslet.2015.08.037","article-title":"Re-wiring regulatory cell networks in immunity by galectin\u2013glycan interactions","volume":"589","author":"Blidner","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2024.10.002_bib98","doi-asserted-by":"crossref","first-page":"643","DOI":"10.12659\/AOT.889396","article-title":"Local expression of myocardial galectin-3 does not correlate with its serum levels in patients undergoing heart transplantation","volume":"18","author":"Beiras-Fernandez","year":"2013","journal-title":"Ann. Transpl."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610124000819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610124000819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:52:06Z","timestamp":1772473926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610124000819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":98,"alternative-id":["S1359610124000819"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2024.10.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2024.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}